Tomoko Kaneyasu

Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types

S. Mori, N. Matsumura, K. Yamaguchi, 2021, JCO precision oncology.

Genomic features of Helicobacter pylori‐naïve diffuse‐type gastric cancer

T. Noda, S. Mori, T. Hirasawa, 2022, The Journal of pathology.

Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types

S. Mori, N. Matsumura, K. Yamaguchi, 2022, JCO precision oncology.

Pathogenicity assessment of variants for breast cancer susceptibility genes based on BRCAness of tumor sample

Y. Miki, T. Noda, S. Mori, 2021, Cancer science.

Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome

Y. Miki, T. Noda, S. Mori, 2020, npj Breast Cancer.

Transcriptomic Analyses of Pretreatment Tumor Biopsy Samples, Response to Neoadjuvant Chemoradiotherapy, and Survival in Patients With Advanced Rectal Cancer

T. Noda, S. Mori, T. Konishi, 2023, JAMA network open.